Reimagine Care Revolutionizes Oncology with AI-Powered Remi Upgrade for Safer, Empathetic Patient Support
March 25, 2026
Reimagine Care unveils a major evolution of Remi, its AI-powered oncology assistant, designed to deepen patient understanding, amplify empathy, strengthen safety protections, and better prepare care teams.
The update centers on oncology-native design tailored to cancer care journeys, deeper patient understanding through AI, expanded safety safeguards with continuous monitoring and clinical guardrails, and AI-assisted redesigns of care-team workflows.
Remi now facilitates more natural, sophisticated conversations by translating patient-reported symptoms into structured clinical insights and clear escalation steps when needed, powered by advanced AI and large language models.
The enhanced platform supports the Virtual Care Center model, helping oncology-trained clinicians quickly interpret conversations, manage symptoms, coordinate care, and reduce avoidable emergency department visits.
Industry context: with over two million new U.S. cancer cases annually, many patients experience symptoms at home between visits, and emergency department visits stay high due to gaps in timely support.
Consumer expectations for immediate, text-based, conversational AI are rising, and Remi aims to meet these in oncology by enabling patients to communicate in their own words and helping clinicians respond earlier and more thoughtfully.
Since its inception, Remi has supported over 10,000 patients and hundreds of thousands of interactions, highlighting its growing role in between-visit cancer care.
The expanded capabilities aim to support more parts of the cancer journey, including advanced therapies like CAR-T outside the hospital, as well as survivorship and end-of-life care.
About Reimagine Care: the company provides an AI-enabled virtual care platform that augments rather than replaces human clinicians, targeting 24/7 access and resolution of 95% of patient needs virtually to reduce after-hours physician burden.
CEO Dan Nardi emphasizes the need for rapid, responsive oncology care akin to other on-demand services.
(Note: Repeated point consolidated in the opening; the core message remains the major evolution of Remi to support faster, safer, patient-centered oncology care.)
Summary based on 1 source
